Article Information
History
- March 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- James Peng*,1,
- Sabrina A Mann*,2,3,
- Anthea M Mitchell*,2,3,
- Jamin Liu*,3,4,
- Matthew T. Laurie*,3,
- Sara Sunshine*,3,
- Genay Pilarowski*,5,
- Patrick Ayscue*,2,
- Amy Kistler2,
- Manu Vanaerschot2,
- Lucy M. Li2,
- Aaron McGeever2,
- Eric D. Chow3,
- IDseq Team6,
- Carina Marquez1,
- Robert Nakamura7,
- Luis Rubio1,
- Gabriel Chamie1,
- Diane Jones8,
- Jon Jacobo8,
- Susana Rojas8,
- Susy Rojas8,
- Valerie Tulier-Laiwa8,
- Douglas Black1,
- Jackie Martinez8,
- Jamie Naso8,
- Joshua Schwab9,
- Maya Petersen9,
- Diane Havlir1,• and
- Joseph DeRisi2,3,•
- 1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
- 2Chan Zuckerberg Biohub, San Francisco, CA 94158, USA
- 3Department of Biochemistry and Biophysics, University of California San Francisco, CA 94143, USA
- 4University of California, Berkeley—University of California, San Francisco Graduate Program in Bioengineering, Berkeley, CA 94720, USA
- 5Department of Pathology, Stanford University, Stanford, CA 94305, USA
- 6Chan Zuckerberg Initiative, Redwood City, CA 94063, USA
- 7California Department of Public Health, Richmond, CA 94804, USA
- 8Unidos en Salud, San Francisco, CA 94143, USA
- 9Division of Biostatistics, University of California, Berkeley, Berkeley, CA 94720, USA
- ↵•Corresponding author: Joseph DeRisi, 1700 4th St., San Francisco, CA 94158, Phone: 415-418-3647, Email: joe{at}derisilab.ucsf.edu Alternate Corresponding Author: Diane Havlir, Box 0874, 995 Potrero Ave., Phone: 415-476-4082, x400, Email: Diane.Havlir{at}ucsf.edu
↵* These authors contributed equally to this work.
Posted March 03, 2021.
Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco
